Your AI-Trained Oncology Knowledge Connection!

Integrating Molecular Testing into Decision Making in NSCLC : Episode 3

Video

October 19, 2022

Best Practices for Accurate Tissue Genotyping in NSCLC

Author(s):

Benjamin Levy, MD,Bhuvana Ramkumar, MD

Dr Bhuvana Ramkumar shares best practices for molecular testing in NSCLC to obtain the most accurate results.

EP: 1.Challenges With and Strategies for Tissue Procurement in NSCLC

EP: 2.Enhancing Communication Among the Multidisciplinary Care Team

Now Viewing

EP: 3.Best Practices for Accurate Tissue Genotyping in NSCLC

EP: 4.Average Turnaround Time for NSCLC Molecular Testing

EP: 5.Types of Tissue Next-Generation Sequencing Platforms in NSCLC

EP: 6.Using Liquid Biopsy for Molecular Testing in NSCLC

EP: 7.Integrating Molecular Testing Results into Electronic Medical Records

EP: 8.Receiving Molecular Testing Results for NSCLC

EP: 9.Financial Considerations with Molecular Testing for Patients With NSCLC

EP: 10.The Future of Molecular Testing in NSCLC

Stay up to date on the most recent and practice-changing oncology data

Subscribe Now!

Latest CME

View All

Video

Navigating the Glaucoma Therapeutic and Surgical Landscape: From Conventional to Cutting-Edge

May 14th 2025 - May 15th 2026

online-activity

Video

Community Oncology Connections™: Community Oncologists’ Role in Selecting Optimal Oral SERD Treatment for HR+/HER2– Breast Cancer | Arizona

May 13th 2025 - Jun 18th 2025

online-activity

Video

16th Annual International Symposium on Ovarian Cancer and Other Gynecological Malignancies™

May 9th 2025 - Jun 14th 2025

online-activity

Latest Conference Coverage

Analysis of PADA-1 Trial Highlights Kinetics and Determinants of ESR1 Mutations in HR+/HER2– Metastatic Breast Cancer

OncLive Polls Spotlight Phase 3 Breast Cancer Studies Generating Buzz Ahead of ASCO 2025

Ribociclib/Endocrine Therapy Yields Similar pCRs Compared With Chemotherapy in HR+ Early Breast Cancer

Emiltatug Ledadotin Shows Early Clinical Activity and Safety in Advanced/Metastatic TNBC

View More Latest Conference Coverage

Advertise

About OncLive

Editorial Board

MJH Life Sciences brands

Privacy

Terms & Conditions

Do Not Sell My Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

Best Practices for Accurate Tissue Genotyping in NSCLC

EP: 1.Challenges With and Strategies for Tissue Procurement in NSCLC

EP: 2.Enhancing Communication Among the Multidisciplinary Care Team

EP: 3.Best Practices for Accurate Tissue Genotyping in NSCLC

EP: 4.Average Turnaround Time for NSCLC Molecular Testing

EP: 5.Types of Tissue Next-Generation Sequencing Platforms in NSCLC

EP: 6.Using Liquid Biopsy for Molecular Testing in NSCLC

EP: 7.Integrating Molecular Testing Results into Electronic Medical Records

EP: 8.Receiving Molecular Testing Results for NSCLC

EP: 9.Financial Considerations with Molecular Testing for Patients With NSCLC

EP: 10.The Future of Molecular Testing in NSCLC

Newsletter

Latest CME

16th Annual International Symposium on Ovarian Cancer and Other Gynecological Malignancies™

Proactive Adverse Event Management for HER2+ BTC Treatments

Community Oncology Connections™: Contextualizing Novel Immunotherapy for Advanced Melanoma – How Do TIL Therapies Fit into Practice? | North Carolina

Navigating the Glaucoma Therapeutic and Surgical Landscape: From Conventional to Cutting-Edge

Community Oncology Connections™: Community Oncologists’ Role in Selecting Optimal Oral SERD Treatment for HR+/HER2– Breast Cancer | Arizona

16th Annual International Symposium on Ovarian Cancer and Other Gynecological Malignancies™

Proactive Adverse Event Management for HER2+ BTC Treatments

Community Oncology Connections™: Contextualizing Novel Immunotherapy for Advanced Melanoma – How Do TIL Therapies Fit into Practice? | North Carolina

Navigating the Glaucoma Therapeutic and Surgical Landscape: From Conventional to Cutting-Edge

Community Oncology Connections™: Community Oncologists’ Role in Selecting Optimal Oral SERD Treatment for HR+/HER2– Breast Cancer | Arizona

16th Annual International Symposium on Ovarian Cancer and Other Gynecological Malignancies™

Proactive Adverse Event Management for HER2+ BTC Treatments

Community Oncology Connections™: Contextualizing Novel Immunotherapy for Advanced Melanoma – How Do TIL Therapies Fit into Practice? | North Carolina

Latest Conference Coverage